BlackRock Group’s PDL BioPharma, Inc. PDLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $581K | Sell |
273,850
-58,359
| -18% | -$124K | ﹤0.01% | 2297 |
|
|
2016
Q3 | $1.11M | Buy |
332,209
+15,840
| +5% | +$53K | ﹤0.01% | 1961 |
|
|
2016
Q2 | $993K | Buy |
316,369
+169,089
| +115% | +$531K | ﹤0.01% | 1971 |
|
|
2016
Q1 | $490K | Sell |
147,280
-102,823
| -41% | -$342K | ﹤0.01% | 2235 |
|
|
2015
Q4 | $885K | Sell |
250,103
-127,686
| -34% | -$452K | ﹤0.01% | 1959 |
|
|
2015
Q3 | $1.9M | Buy |
377,789
+31,059
| +9% | +$156K | ﹤0.01% | 1513 |
|
|
2015
Q2 | $2.23M | Buy |
346,730
+31,993
| +10% | +$206K | ﹤0.01% | 1492 |
|
|
2015
Q1 | $2.22M | Buy |
314,737
+50,970
| +19% | +$359K | ﹤0.01% | 1428 |
|
|
2014
Q4 | $2.04M | Sell |
263,767
-43,683
| -14% | -$337K | ﹤0.01% | 1456 |
|
|
2014
Q3 | $2.3M | Buy |
307,450
+6,948
| +2% | +$51.9K | ﹤0.01% | 1353 |
|
|
2014
Q2 | $2.91M | Buy |
300,502
+79,391
| +36% | +$769K | ﹤0.01% | 1290 |
|
|
2014
Q1 | $1.84M | Buy |
221,111
+19,349
| +10% | +$161K | ﹤0.01% | 1607 |
|
|
2013
Q4 | $1.7M | Sell |
201,762
-19,884
| -9% | -$168K | ﹤0.01% | 1616 |
|
|
2013
Q3 | $1.77M | Buy |
221,646
+20,091
| +10% | +$160K | ﹤0.01% | 1525 |
|
|
2013
Q2 | $1.56M | Buy |
+201,555
| New | +$1.56M | ﹤0.01% | 1431 |
|